Journal profile · Medicine-Medicine (miscellaneous)
Immuno
ISSN 2673-5601 · MDPI AG · Switzerland
Immuno: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.7 (journal website); fully open access; APC charged, amount not published; review about 7 weeks (community reports); 65 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Immuno is published by MDPI AG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses, together about 26.7% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
The scope of Immuno covers a broad range of immunology topics, including the following: Innate immunity; Acquired immunity; Synthetic immunity; Structural immunology; Immunogenetics, immunogenomics, immunoproteomics, immunometabolomics; Infectious immunology and vaccines; Cancer immunology; Immunotherapy; Autoimmunity and immunoregulation; Developmental immunology; Immunodeficiency; Reproductive immunology; Transplantation immunology; Immunodermatology; Mucosal immunology; Neuroimmunology; Immunopathology and immunohistology; Clinical/Translational immunology. Immuno accepts submissions that provide a thorough understanding of these areas, offering insights into the body's response to pathogens, artificial immune responses, molecular components, genetics, infectious diseases, cancer treatment, self-antigen response, developmental disorders, fertility, organ transplantation, skin interactions, mucosal tissues, nervous system interactions, disease analysis, and application of immunology in clinical settings.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (miscellaneous)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology9.2%
- Cancer Immunotherapy and BiomarkersMedicine8.8%
- Immunotherapy and Immune ResponsesImmunology and Microbiology8.8%
- Immune cells in cancerImmunology and Microbiology6.6%
- COVID-19 Clinical Research StudiesMedicine5.5%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.5%
- CAR-T cell therapy researchMedicine5.1%
- Reproductive System and PregnancyImmunology and Microbiology5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.4Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 20OpenAlex ·
- i10-index
- 47OpenAlex ·
- 2-year mean citedness
- 2.63OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 99.22%LetPub ·
Volume
- Articles per year
- 66LetPub ·
Articles by year OpenAlex count · 269 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 57 | 57 | 20 |
| 2025 | 65 | 65 | 167 |
| 2024 | 39 | 39 | 236 |
| 2023 | 23 | 23 | 199 |
| 2022 | 40 | 40 | 525 |
| 2021 | 45 | 45 | 345 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 7 weeksLetPub ·
- Submission to first decision
- 21.2 daysPublisher website ·
- Acceptance to publication
- 3.6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,000 | Yes | CC BY | |
| OpenAlex | CHF 1,000 | — | — | |
| LetPub | CHF 1,000 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 200 words
- Reference style
- Author–date
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required, 3
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted20
- articleArticle: These are original research manuscripts. The work should report scientifically sound experiments and provide a substantial amount of new information.Length not stated
- book reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief communicationAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- case reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- commentaryAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- conference reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- editorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- hypothesisAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- letterAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- opinionAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- perspectiveAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- protocolAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- registered reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- scoping reviewA Scoping Review type can be submitted as a Review. The structure is similar to that of a review. Scoping reviews should strictly follow the PRISMA extension fo…Length not stated
- systematic reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- technical noteAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- tutorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- viewpointAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
MDPI follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed: Make substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; Draft the work or review it critically for important intel…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.” All authors mus…
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statements are required for all articles published with MDPI. During the peer review and editorial decision process, authors can be asked to share existing datasets or raw data that have been analyzed in the manuscript, and whether they will be made available to other researchers following publication. Authors will also be asked for the details of any existing datasets that have …
Source ↗Publisher website ·- Publication ethics Publication Ethics Statement
MDPI is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines. The editors of this journal enforce a rigorous peer review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification,…
Source ↗Publisher website ·- License & copyright Copyright / Open Access
Articles published in Immuno will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and con…
Source ↗Publisher website ·- Open access Open access publication fees
If you transfer your manuscript to another open access (OA) journal, you will be charged an Article Processing Charge (APC) if your article is accepted for publication. The APC for each journal can be found on the individual journal’s website. For more information about APCs, please see here.
Source ↗Publisher website ·- Peer review Editorial Process and Peer Review
Originality requirement; no prior publication or concurrent submission. Model summary
All submissions are thoroughly peer-reviewed by experts within the field and undergo a structured editorial workflow designed to ensure quality, transparency, and scientific integrity. The full editorial procedure is available on the Editorial Process page and is also provided below. Pre-check Pre-check consists of a technical pre-check performed by the Editorial Office and an editorial pre-check …
Source ↗Publisher website ·- Preprints Preprints and Conference Papers
Immuno accepts submissions that have previously been made available as preprints provided that they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. MDPI operates Preprints, a preprint server to which submitted papers can be uploaded directly after completing journal submission. Note that Preprints operates independently…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- MDPI AG
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-5601
- Latest issue on the website
- Volume 6 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Immuno
What CAS zone is Immuno in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immuno is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immuno?
The journal's website gives an impact factor of 2.7 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.1, h-index 20.
How long does peer review take at Immuno?
Authors report an average review time of about 7 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Immuno?
According to the journal's author guidelines: Abstract: ≤ 200 words; Reference style: Author–date; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required, 3; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Immuno?
According to LetPub and DOAJ records, Immuno is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.
Is Immuno open access, and what is the APC?
Immuno is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .